Skip to main content
. 2017 Sep 30;18(10):2076. doi: 10.3390/ijms18102076

Figure 4.

Figure 4

Bioavailability of the novel TGF-β1 formulation in rabbit vitreous. * p < 0.01 vs. basal level (control animals) (35.60 ± 10 pg/mL). The curve was normalized to TGF-β1 basal levels.